José Ignacio
García Doval
![Foto de José Ignacio](/img/nophoto.png)
![Foto de Complejo Hospitalario Universitario de Albacete](/img/noimage_org.png)
Complejo Hospitalario Universitario de Albacete
Albacete, EspañaPublicacións en colaboración con investigadores/as de Complejo Hospitalario Universitario de Albacete (7)
2022
-
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain
Pediatric Dermatology, Vol. 39, Núm. 4, pp. 557-562
2017
2016
-
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort
Journal of Dermatological Treatment, Vol. 27, Núm. 3, pp. 203-209
2015
-
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time
Actas Dermo-Sifiliograficas, Vol. 106, Núm. 8, pp. 638-643
-
Riesgo de reactivación de hepatitis B pasada en pacientes con psoriasis tratados con biológicos. Análisis retrospectivo de 20 casos. Registro de BIOBADADERM
Actas Dermo-Sifiliograficas, Vol. 106, Núm. 6, pp. 477-482
-
Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice
Journal of Dermatological Treatment, Vol. 26, Núm. 6, pp. 502-506
2010
-
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1751-1755